Multistability in platelets and their response to gold nanoparticles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 7, Issue 4, 2011, Pages 376-384

  Deb, Suryyani ^a   Patra, Hirak K ^a   Lahiri, Prabir ^a   Dasgupta, Anjan Kr ^a   Chakrabarti, Kuntal ^b   Chaudhuri, Utpal ^c  

^a UNIVERSITY OF CALCUTTA   (India)

^b S N BOSE NATIONAL CENTRE FOR BASIC SCIENCES   (India)

^c MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Activation; Adhesion; Gold nanoparticle; Granule release; Multi stability; Nanosafety measure; Thrombotic risk

Indexed keywords

GOLD NANOPARTICLE; GRANULE RELEASE; MULTI-STABILITY; NANOSAFETY MEASURE; THROMBOTIC RISK;

AMINO ACIDS; GOLD; NANOPARTICLES; PHOSPHORYLATION;

PLATELETS;

GOLD NANOPARTICLE; MEPACRINE; PADGEM PROTEIN;

ARTICLE; CELL SUSPENSION; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; PARTICLE SIZE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION;

ADENOSINE TRIPHOSPHATE; BLOOD PLATELETS; GOLD; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, SCANNING; PHOSPHORYLATION; PLATELET AGGREGATION; TYROSINE;

EID: 79960724823     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.01.007     Document Type: Article

References (41)

1. Patra H.K., Banerjee S., Chaudhuri U., et al. Cell selective response to gold nanoparticle. Nanomedicine 2007, 3:11-119.
2. Han G., Ghosh P., De M., Rotello V.M. Drug and gene delivery using gold nanoparticles. Nanobiotechnology 2007, 3:40-45.
3. Geys J., Nemmar A., Verbeken E., et al. Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ Health Perspect 2008, 116:1607-1613.
4. Oberdrster G., Stone V., Donaldson K. Toxicology of nanoparticles: A historical perspective. Nanotoxicology 2007, 1:2-25.
5. Morris J.B., Olzinski A.R., Bernard R.E., et al. 38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment. Arterioscler Thromb Vasc Biol 2008, 28:265-271.
6. Rodvien R., Mielke C.H. Role of platelets in hemostasis and thrombosis. West J Med 1976, 125:181-186.
7. Kichler T.S. Platelet biology - An overview. Transfus Altern Transfus Med 2006, 8:79-85.
8. Mazzucato M., Cozzi M.R., Pradella P., Perissinotto D., Malmstro M.A., Morgelin M.M., et al. Vascular PG-M/versican variants promote platelet adhesion at low shear rates and cooperate with collagens to induce aggregation. Arterioscler Thromb Vasc Biol 2008, 28:265-271.
9. Willoughby S., Holmes A., Loscalzo J. Platelets and cardiovascular disease. Eur J Cardiovasc Nurs 2002, 1:273-288.
10. Tendera M., Wojakowski W. Role of antiplatelet drugs in the prevention of cardiovascular events. Thromb Res 2003, 110:355-359.
11. Deb S., Chatterjee M., Bhattacharya J., Lahiri P., Chaudhuri U., Pal Choudhuri S., et al. Role of purinergic receptors in platelet-nanoparticle interactions. Nanotoxicology 2007, 1:93-103.
12. Akchurin G.G., Akchwin G.G., Ivanovi A.N., Kirichuk V.F., Terentyuk G.S., Khlebtsov B.N., et al. Influence of gold nanoparticles on platelets functional activity in vitro. Plasmonics in Biology and Medicine 2008, Vol. 6869. SPIE, Bellingham, WA. 10.1117/12.765076. V. Tuan Vo-Dinh, J.R. Lakowicz (Eds.).
13. Radomski A., Jurasz P., Alonso-Escolano D., Drews M., Morandi M., Malinski T., Radomski M.W. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 2005, 146:882-893.
14. Lu S.H., Tun M.H.N., Mei Z.J., Chia G.H., Lim X., Sow C.H. Improved hydrophobicity of carbon nanotube arrays with micropatterning. Langmuir 2009, 25:12806-12811.
15. Ghosh P., Han G., De M., Kim C.K., Rotello V.M. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 2008, 60:1307-1315.
16. Huff T.B., Tong L., Zhao Y., Hansen M.N., Cheng J.X., Wei A. Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine 2007, 2:125-132.
17. Arnida Malugin A., Ghandehari H. Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J Appl Toxicol 2010, 30:212-217.
18. Singha S., Datta H., Dasgupta A.K. Size dependent chaperon properties of gold nanoparticles. J. Nanosci. Nanotechnol 2010, 10:826-832.
19. Born G.V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962, 194:927-929.
20. Higashi T, Isomoto A, Tyuma I, Kakishita E, Uomoto M, Nagai K. Quantitative and continuous analysis of ATP release from blood platelets with firefly luciferase luminescence. Thromb Haemos 1985; 53:65-69.
21. Panzer S., Eichelberger B., Koren D., Kaufmann K., Male C. Monitoring survival and function of transfused platelets in Bernard-Soulier syndrome by flow cytometry and a cone and plate(let) analyzer (Impact-R). Transfusion 2007, 47:103-106.
22. Ray T, Maity P C, Banerjee S, Deb S, Dasgupta A K, Sarkar S, et al. Vitamin C prevents cigarette smoke induced atherosclerosis in guinea pig model. J Atheroscler Thromb 2010 (in press).
23. Zilla P., Fasol R., Hammerle A., Yildiz S., Kadletz M., Laufer G., Wollenek G., Seitelberger R., Deutsch M. Scanning electron microscopy of circulating platelets reveals new aspects of platelet alteration during cardiopulmonary bypass. Tex Heart Inst J 1987, 14:13-21.
24. Walkowiak B., Kralisz U., Michalec L., Majewska E., Kiewicz W.K., Ligocka A., et al. Comparison of platelet aggregability and P-selectin surface expression on platelets isolated by different methods. Thromb Res 2000, 99:495-502.
25. Fälker K., Lange D., Presek P. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets. Thromb Haemost 2005, 93:880-888.
26. Michelson A.D. Flow cytometry. A clinical test of platelet function. Blood 1996, 87:4925-4936.
27. Mandal D., Maran A., Yaszemski M.J., Bolander M.E., Sarkar G. Uptake of gold nanoparticles directly cross-linked with carrier peptides by osteosarcoma cells. J Mater Sci Mater Med 2009, 20:347-350.
28. Mayer A., Vadon M., Rinner B., Novak A., Wintersteiger R., Fröhlich E. The role of nanoparticle size in hemocompatibility. Toxicology 2009, 258:139-147.
29. Shrivastava S, Bera T, K. Singh S, Singh G, Ramachandrarao P, Dash D. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano 2009; 3:1357-64.
30. Chithrani B.D., Ghazani A.A., Chan W.C. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Letter 2006, 6:662-668.
31. White J.G. Platelets are covercytes, not phagocytes: Uptake of bacteria involves channels of the open canalicular system. Platelets 2005, 16:121-131.
32. Basani R.B., D'Andrea G., Mitra N., Vilaire G., Richberg M., Kowalska M.A., et al. RGD-containing peptides inhibit fibrinogen binding to platelet alpha(IIb)beta3 by inducing an allosteric change in the amino-terminal portion of alpha(IIb). J Biol Chem 2001, 276:13975-13981.
33. Golden A., Brugge J.S., Shattil S.J. Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins. J Cell Biol 1990, 111:3117-3127.
34. Harrison P., Cramer E.M. Platelet alpha-granules. Blood Rev 1993, 7:52-62.
35. Taylor M.L., Misso N.L., Stewart G.A., Thompson P.J. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects. Clin Exp Allergy 1996, 26:202-215.
36. Laffan M.A., Manning R.A. Investigation of hemostasis. Practical Haematology 2001, 339-390. Harcourt Publishers Limited, London, UK. 9th ed. S.M. Lewis, B.J. Bain, I. Bates (Eds.).
37. Daniel J.L., Dangelmaier C., Jin J., Ashby B., Smith J.B., Kunapuli S.P. Molecular basis for ADP-induced platelet activation. J Biol Chem 1998, 273:2024-2029.
38. Huang P.Y., Hellums J.D. Aggregation and disaggregation kinetics of human blood platelets Part II. Shear-induced platelet aggregation. Biophys J 1993, 65:344-353.
39. Merten M., Thiagarajan P. P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation 2000, 102:1931-1936.
40. Dubnau D., Losick R. Bistability in bacteria. Mol Microbiol 2006, 61:564-572.
41. Ozbudak E.M., Thattai M., Lim H.N., Shraiman B.I., Oudenaarden A.V. Multistability in the lactose utilization network of Escherichia coli. Nature 2004, 427:737-740.